How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.

doi:10.1186/1471-2407-12-320

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.

BMC cancer - 28 Jul 2012

Watts Kaaren J, Meiser Bettina, Mitchell Gillian, Kirk Judy, Saunders Christobel, Peate Michelle, Duffy Jessica, Kelly Patrick J, Gleeson Margaret, Barlow-Stewart Kristine, Rahman Belinda, Friedlander Michael, Tucker Kathy

Abstract excerpt

BACKGROUND: Germline BRCA1 and BRCA2 mutation testing offered shortly after a breast cancer diagnosis to inform women's treatment choices - treatment-focused genetic testing 'TFGT' - has entered clinical practice in specialist centers and is likely to be soon commonplace in acute breast cancer management, especially for younger women. Yet the optimal way to deliver information about TFGT to younger women newly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Clinical Protocols

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Genetic Testing

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 22838957
DOI: 10.1186/1471-2407-12-320
PMCID: PMC3472271

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.PMID 22838957Read ↗

Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.Semantic proximity Read ↗

Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.Semantic proximity Read ↗

When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.Semantic proximity Read ↗

The Breast Cancer Genetic Testing Experience: Probing the Potential Utility of an Online Decision Aid in Risk Perception and Decision MakingSemantic proximity Read ↗

The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making.Semantic proximity Read ↗

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.Semantic proximity Read ↗

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.Semantic proximity Read ↗

Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.Semantic proximity Read ↗

Psychosocial experiences and outcomes for individuals with breast cancer after mainstream genetic testingSemantic proximity Read ↗

Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.Semantic proximity Read ↗

Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Semantic proximity Read ↗

Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.